AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Endovascular Preparation for Kidney Tranplantation

Recruitingn/aAges 18 Years - 85 YearsAllHospices Civils de Lyon
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This national study is a feasibility study. It wants to validate all stages of the endovascular preparation of the iliac axis up to the kidney transplant for patients in whom the installation of a tailor-made endoprosthesis was necessary beforehand. These patients are currently at a therapeutic impasse. This strategy of renal transplantation on an iliac artery endoprosthesis could ultimately give them access to the transplant with an improvement in quality of life and survival, for lower costs of care for the hospital and safety. less social than treatment by hemodialysis

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patient from 18 to 85 years old (beyond 85 years old, guidance must remain exceptional) 2. Patients with chronic renal failure 3. Waiting for a kidney transplant 4. Who have a vascular contraindication to renal transplantation because of their anatomical constraints. Exclusion Criteria: 1-All criteria contraindicating kidney transplant other than for arterial anatomical problems: All criteria contraindicating kidney transplant other than for arterial anatomical problems: * A progressive cancer, which is not cured, * An uncontrolled infectious disease, * Severe cardiovascular or respiratory disease making general anesthesia impossible, * Unstabilized psychiatric disorders or illness, * Dementia proven to have progressed after specialist advice * Major obesity, with a body mass index greater than 50 kg/m2 * Patient refusal 2. Patient under curatorship 3. Pregnant woman 4. Patients for whom it will not be possible to organize regular medical follow-up
๐Ÿ’Š

What it tests

  • This is an observational and retrospective study
๐Ÿ“

Where

1 site
HCL Hopital Louis Pradel
Bron, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy